Founder Directory
Built by Keitoto
Founders3
Known for these resultsRole67%Role is parsed from founder titles in yc.db. Known for 67% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company0%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 0% of these rows have at least one match.School33%School is matched from bios, case-sensitive for acronyms. 33% of these rows have at least one match.
- Noah AuerhahnFounder/CEO · Uncommon TherapeuticsW25Healthcare · San Francisco
- Ryan LimFounder · Uncommon TherapeuticsW25Healthcare · San Francisco
- Brian PetkovFounder/CEO · Junction BioscienceW24Healthcare · New York
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Noah AuerhahnUncommon TherapeuticsFounder/CEOWinter 2025HealthcareSan Francisco, United States2—Ryan LimUncommon TherapeuticsFounderWinter 2025HealthcareSan Francisco, United States2—Brian PetkovJunction BioscienceFounder/CEOWinter 2024HealthcareNew York, United States——Showing 1–3 of 3 founders
Brian Petkov
Founder/CEO·Junction Bioscience
PRIMARY INFO
RoleFounder/CEO
Team size—
BatchWinter 2024
LocationNew York, United States
Company statusActive
StageEarly
BIO
Brian is a theoretical physicist and drug hunter with degrees in mathematics and chemistry from Duke University and doctoral training from NYU. He was previously the first employee and Vice President at a computational drug design startup where he led the Machine Learning operation and grew a 30-person team to success on previously-undruggable targets.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
CredentialsPhD
DisciplineEngineerKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
AI Hypothesis Engine for Molecular Discovery